DAWN EBITDA Margin

Day One Biopharmaceuticals Inc · EBITDA Margin

DAWN logo

DAWN EBITDA Margin

Latest reported-66.70%
DAWN TTM EBITDA Margin (-2016.63% → -66.70%)
High-resolution chart · PNG

DAWN ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Day One Biopharmaceuticals Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-66.7029%
-106.0304%
-45.8543%
-36.517%
-65.8145%
-80.6744%
-2,016.626%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.